Question 1

Does Verition Fund Management own TXG stock?

Accepted Answer

No. Verition Fund Management exited its TXG (10x Genomics) position in Q3 2025. Its Q2 2025 13F listed 107,957 shares worth $1.3M.

Question 2

How many shares of TXG does Verition Fund Management own?

Accepted Answer

None since Q3 2025, when Verition Fund Management exited the position. Its Q2 2025 13F listed 107,957 shares worth $1.3M.

Question 3

What is Verition Fund Management's TXG position worth?

Accepted Answer

Verition Fund Management's TXG position was worth $1.3M in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Verition Fund Management buying or selling TXG?

Accepted Answer

In Q3 2025, Verition Fund Management exited its entire TXG position.

Question 5

When did Verition Fund Management first buy TXG?

Accepted Answer

Verition Fund Management first reported TXG in its Q2 2021 13F and listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$11.69	0
2025-Q2	Decreased	107,957	-43.7%	$1.3M	0.0%	$11.58	0
2025-Q1	New	191,643	—	$1.7M	0.0%	$8.73	36
2024-Q4	Exited	0	-100.0%	$0	0.0%	$14.36	0
2024-Q3	Increased	13,860	+26.3%	$312,959	0.0%	$22.67	29